Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

As previously reported in the Prior 8-K, on March 9, 2022, the Company's Board of Directors (the "Board") appointed Julie Goldstein and Patricia Wilber to the Board, effective March 15, 2022. At the time of the Prior 8-K filing, the Board had not yet determined the Board committee assignments for Ms. Goldstein and Ms. Wilber.

This Current Report on Form 8-K/A hereby amends the Prior 8-K to disclose that on May 5, 2022, the Board appointed (i) Ms. Goldstein to the Nominating and Corporate Governance Committee and (ii) Ms. Wilber to the Audit Committee. Following these appointments, the three standing committees of the Board are constituted as follows:

Audit Committee: Thomas M. Patton (Chair), Michael G. Atieh, John P. Gandolfo and Patricia Wilber.

Nominating and Corporate Governance Committee: Thomas J. Errico, M.D. (Chair), F. Peter Cuneo and Julie Goldstein.

Compensation Committee: Trevor J. Moody (Chair), Thomas J. Errico, M.D., and John P. Gandolfo.

© Edgar Online, source Glimpses